3L M Ortega,D R Schultz,O Lenz,et al.Lupus nephritis:pathologic fea-tures,epidemiology and a guide to therapeutic decision[sJ].Lupus,2010,(19):557-574.
5Mitwalli A H,Al Wakeel J S,Hur-raib S,et al.Comparison of high and low dose of cyclophosphamide in lu-pus nephritis patients:a long-term randomized controlled tria[lJ].Saudi J Kidney Dis Transpl,2011,22(5):935-940.
7Anselm Mak,Alicia A.C.Cheak,Jason Y.S.Tan.Mycophenolate mofetil is as efficacious,but safer than,cyclophos-phamide in the trratment of prolifera-tive lupus nephritis:a meta-analysis and meta-regression[J].Rheumatolo-gy,2009,48:944-952.
4Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group[ J]. N Engi J Med,2000,343 (16) :1156 -1162.
5MoroniG, Doria A, MoscaM, etal. Arandomized pilot trial comparing eylosporine and azathioprine formaintenanee therapy in diffuse lupusnephritisver four years [ J ]. Clin JAm SoeNephrol,2006,1 ( 5 ) :925 - 932.
6Wang HY, Cui TG, Hou FF, et al. Induction treatment of proliferative lupus nephritis with leflunomidecde combined th prednisone: aprospective muhieentre observational study[J]. Lups,2008,17(7) :638 -644.
7Iwasaki T, Hamano T, Aizawa K, et al. A case of systemic lu- pus erythematosus (SLE) successfully treated with mizorib- ine (Sredinin) ] [ J]. Ryumachi, 1994,34 ( 5 ) : S85 - S89.
